Bavarian Nordic A/S BV3.DE Stock
Bavarian Nordic A/S Price Chart
Bavarian Nordic A/S BV3.DE Financial and Trading Overview
Bavarian Nordic A/S stock price | 25.3 EUR |
Previous Close | 28.55 EUR |
Open | 28.45 EUR |
Bid | 28.4 EUR x N/A |
Ask | 28.49 EUR x N/A |
Day's Range | 28.45 - 28.45 EUR |
52 Week Range | 23.12 - 55.1 EUR |
Volume | 5 EUR |
Avg. Volume | 357 EUR |
Market Cap | 2.47B EUR |
Beta (5Y Monthly) | 1.410344 |
PE Ratio (TTM) | 51.727272 |
EPS (TTM) | 0.56 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BV3.DE Valuation Measures
Enterprise Value | -709158208 EUR |
Trailing P/E | 51.727272 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.6051912 |
Price/Book (mrq) | 0.23018917 |
Enterprise Value/Revenue | -0.174 |
Enterprise Value/EBITDA | -0.825 |
Trading Information
Bavarian Nordic A/S Stock Price History
Beta (5Y Monthly) | 1.410344 |
52-Week Change | 5.35% |
S&P500 52-Week Change | 20.43% |
52 Week High | 55.1 EUR |
52 Week Low | 23.12 EUR |
50-Day Moving Average | 26.17 EUR |
200-Day Moving Average | 29.48 EUR |
BV3.DE Share Statistics
Avg. Volume (3 month) | 357 EUR |
Avg. Daily Volume (10-Days) | 326 EUR |
Shares Outstanding | 77.77M |
Float | 73.73M |
Short Ratio | N/A |
% Held by Insiders | 0.090% |
% Held by Institutions | 30.51% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 7.37% |
Operating Margin (ttm) | 12.02% |
Gross Margin | 61.16% |
EBITDA Margin | 21.05% |
Management Effectiveness
Return on Assets (ttm) | 2.43% |
Return on Equity (ttm) | 3.70% |
Income Statement
Revenue (ttm) | 4.08B EUR |
Revenue Per Share (ttm) | 57.15 EUR |
Quarterly Revenue Growth (yoy) | 291.19% |
Gross Profit (ttm) | 1.7B EUR |
EBITDA | 859.46M EUR |
Net Income Avi to Common (ttm) | 300.93M EUR |
Diluted EPS (ttm) | 0.55 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.97B EUR |
Total Cash Per Share (mrq) | 40.28 EUR |
Total Debt (mrq) | 86.7M EUR |
Total Debt/Equity (mrq) | 0.95 EUR |
Current Ratio (mrq) | 2.863 |
Book Value Per Share (mrq) | 123.594 |
Cash Flow Statement
Operating Cash Flow (ttm) | -18438000 EUR |
Levered Free Cash Flow (ttm) | -1088122240 EUR |
Profile of Bavarian Nordic A/S
Country | Germany |
State | N/A |
City | Hellerup |
Address | Philip Heymans Alle 3 |
ZIP | 2900 |
Phone | 45 33 26 83 83 |
Website | https://www.bavarian-nordic.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1040 |
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Q&A For Bavarian Nordic A/S Stock
What is a current BV3.DE stock price?
Bavarian Nordic A/S BV3.DE stock price today per share is 25.3 EUR.
How to purchase Bavarian Nordic A/S stock?
You can buy BV3.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bavarian Nordic A/S?
The stock symbol or ticker of Bavarian Nordic A/S is BV3.DE.
Which industry does the Bavarian Nordic A/S company belong to?
The Bavarian Nordic A/S industry is Biotechnology.
How many shares does Bavarian Nordic A/S have in circulation?
The max supply of Bavarian Nordic A/S shares is 78.75M.
What is Bavarian Nordic A/S Price to Earnings Ratio (PE Ratio)?
Bavarian Nordic A/S PE Ratio is 45.17857000 now.
What was Bavarian Nordic A/S earnings per share over the trailing 12 months (TTM)?
Bavarian Nordic A/S EPS is 0.56 EUR over the trailing 12 months.
Which sector does the Bavarian Nordic A/S company belong to?
The Bavarian Nordic A/S sector is Healthcare.